Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKN1 | Q16512 | 4/20 | 0.52 |
| ▸ | PAK4 | O96013 | 3/20 | 0.52 |
| ▸ | PAK1 | Q13153 | 7/20 | 0.51 |
| ▸ | PAK2 | Q13177 | 5/20 | 0.51 |
| ▸ | PAK3 | O75914 | 3/20 | 0.51 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.51 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13554002 | 0.89 | PKN1 (0.54) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13553548 | 0.88 | PKN1 (0.59) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL14824742 | 0.87 | PKN1 (0.60) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13554116 | 0.87 | PKN1 (0.60) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL15035963 | 0.86 | PAK1 (0.52) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL12807689 | 0.85 | PKN1 (0.56) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13554112 | 0.84 | PKN1 (0.55) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13553556 | 0.84 | PKN1 (0.54) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13554111 | 0.84 | PKN1 (0.54) | PKN1PAK4PAK1PAK2PAK3 | |
| SCHEMBL13553513 | 0.84 | PKN1 (0.54) | PKN1PAK4PAK1PAK2PAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013043232-A2 | 8-ETHYL-6-(ARYL)PYRIDO [2,3-D]PYRIMIDIN-7(8H) -ONES FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS AND CANCER | AFRAXIS, INC. (US) | 2013-03-28 | — | — | WO | disclosed |